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Background: The biotransformation of steroids by fungal biocatalysts has been recognized for many years. There
are numerous fungi of the genus Aspergillus which have been shown to transform different steroid substances. The
possibility of using filamentous fungi Aspergillus brasiliensis cells in the biotransformation of androsta-1,4-diene-3,17-dione,
was evaluated.
Methods: The fungal strain was inoculated into the transformation medium which supplemented with
androstadienedione as a substrate and fermentation continued for 5 days. The metabolites were extracted and
isolated by thin layer chromatography. The structures of these metabolites were elucidated using 1H-NMR, broadband
decoupled 13C-NMR, EI Mass and IR spectroscopies.
Results: The fermentation yielded one reduced product: 17β-hydroxyandrost-1,4-dien-3-one and two hydroxylated
metabolites: 11α-hydroxyandrost-1,4-diene-3,17-dione and 12β-hydroxyandrost-1,4-diene-3,17-dione.
Conclusions: The results obtained in this study show that A. brasiliendsis could be considered as a biocatalyst for
producing important derivatives from androstadienedione.
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Microbial biotransformation by the whole cell micro-
organisms is economically and ecologically a competitive
tool for the biotechnological professionals in search
of new techniques to manufacture valuable chemicals,
pharmaceutical and agrochemical compounds [1,2]. The
production of steroid drugs and hormones is one of the
best examples of the successful application of microbial
technology in large scale industrial processes [3]. A large
number of bacterial and fungal species are able to bio-
transform steroid compounds [4]. Among them, there
are numerous fungi of the genus Aspergillus including A.
wentti, A. niger, A. nidulans, A. ochraceus, A. parasiticus,
A. oryzae, A. flavus, A. tamari, A. parasiticus and A. fumi-
gatus which have been used for the biotransformation of
many steroids and shown to mediate hydroxylation, oxida-
tion, reduction, double bond formation and epoxidation
of various steroid substances [5-7]. Insertion of a hydroxyl* Correspondence: farzadkf@yahoo.com
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article, unless otherwise stated.group to a steroid molecule is one of the most important
steps in the production of steroidal derivatives which is
carried out by many of filamentous fungi. Several posi-
tions in the steroid molecules can be hydroxylated by va-
rious microbial strains via their hydroxylase enzyme [8].
The filamentous fungi, Aspergillus brasiliensis is a bise-
riate black species, described and named within Aspergillus
section Nigri, by Varga et al. in 2007. It is differentiable
from the other black aspergilla because of its unique
morphology, extrolite profiles and genotypic features [9].
Literature review shows that there is no report indicating
the ability of this filamentous fungus to modify the struc-
ture of steroids. In the present work, the capability of
A. brasiliensis was evaluated for the biotransformation of
androsta-1,4-diene-3,17-dione (ADD) as an exogenous
substrate. ADD is one of the most important steroids,
which is used as a precursor for preparing some
pharmaceutically-interesting steroids. It is commercially
produced by the microbiological transformation of
β-sitosterol and cholesterol [8]. It is presently used in the
industrial synthesis of estradiol or estrone [4,10].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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reported by some other fungi, such as Mucor racemosus,
Acremonium strictum, Cephalosporium aphidicola and




ADD was purchased from Sigma- Aldrich. All other che-
micals and reagents used, were of analytical grade and
commercially available.
Microorganism
The fungal strain A. brasilliensis PTCC 5298 was pur-
chased From Iranian Research Organization for Science
and Technology (IROST).
Cultures of fungi were grown at 26°C for 5 days until
good sporulation was obtained on Czapec medium, con-
sisting of 30 g sucrose, 2.0 g NaNO3, 1.0 g K2HPO4, 0.50 g
MgSO4, 0.50 g KCl, 0.01 g FeSO4, 15 g Agar and 1000 ml
DW, based on IROST catalogue for this fungus [15]. Stock
cultures were maintained at 4°C on Czapec medium
slopes and freshly subcultured before use in transform-
ation experiments. The organism was transferred to fresh
medium and refreshed every two weeks.
Inoculum preparation and biotransformation process
Spores freshly obtained from Czapec slopes were washed
with distilled water (DW) containing Tween-80 and
transferred aseptically into 500 ml flasks containing 100
ml sterile medium, in a biological safety cabinet (pH of
the medium was adjusted to 7.4 before sterilization).
Volume of inoculums, containing 1 × 106 spores, was
used in all experiments unless otherwise stated. After cul-
tivation at 26°C for 2 days on a rotary shaker (125 rpm)
and pellet formation, ADD (100 mg) was dissolved in 1 ml
acetone and aseptically added to each flask. A parallel
control without substrate and also a culture medium, con-
taining substrate but no microorganism were run concur-
rently (as control cultures). Biotransformation was carried
out under above condition for further 5 days.
Sampling was carried out every 24 h. The samples
were extracted with three volumes of chloroform and
the transformation was then checked using thin layer
chromatography (TLC).
After detecting the transformation on TLC plate, the
fermentation was conducted on the larger scale.
Ten 1000 ml-Erlenmeyer flasks were filled with 200 ml
cultivation medium. The culture media were incubated
under the same conditions and then 1000 mg of substrate,
(dissolved in 10 ml acetone) was distributed evenly among
the flasks and process continued for 5 days.
All the experiments were performed in duplicate.Product isolation and analyses
At the end of incubation, the fungus mycelium was sepa-
rated from the broth by filtration and the mycelium was
rinsed with DW. Mycelia and the filtrate were separately
extracted with chloroform (3 volumes), dried over anhyd-
rous sodium sulfate and concentrated under vacuum. The
residue was analyzed by TLC, then loaded on chromato-
graphy plates and fractionated with chloroform/acetone
(6.5:3.5 v/v) as the eluent solvent. The metabolites were
then separated from silica gel using a mixture of metha-
nol/chloroform/acetone (three times). The transformation
products were analyzed and identified using different
spectroscopic data (13C NMR, 1H NMR, FTIR and MS).
Instruments
Melting points (mp) were determined on thermoscien-
tific 9200 apparatus and were uncorrected.
1H and 13C nuclear magnetic resonances (NMR) spectra
were recorded using a Bruker DRX (Avance 500) spec-
trometer (Rheinstetten, Germany) at 500 and 125 MHz,
respectively, in CDCl3 with tetramethylsilane (TMS) as
the internal standard. Chemical shifts (δ) are given in
parts per million (ppm) relative to TMS. The coupling
constants (J) are given in hertz (Hz). Infrared (IR) spectra
were recorded on a Perkin-Elmer 843 spectrometer with
KBr as a diluent. Mass spectra (MS) were obtained using
Agilent 6410 Triple Quadrupole mass spectrometer. TLC
was conducted on 0.25 mm thick layers of silica gel G
(Kieselgel 60 HF254+366, Merck). Chromatography plates
were developed with chloroform/acetone (3.5:6.5, v/v)
and visualized by spraying the plates with a mixture of
methanol/ sulfuric acid (6:1, v/v) and heating them in an
oven at 100°C for 3 min until the colors developed.
The compounds were also visualized under a UV lamp
(Strstedt– Gruppe HP-UVIS) at 254 nm.
Results
Microbial transformation of ADD by A. brasiliensis in 5
days resulted in the formation of three hydroxysteroid-1,4-
dien-3-one derivatives (II to IV), presented in Figure 1. No
transformation occurred in the control media. Steroid
products were characterized using different spectroscopic
data (13C NMR, 1H NMR, FTIR and MS) and melting
points.
The analytical data for compounds II–IV are men-
tioned in a respective order. 13C NMR assignments for
the substrates and metabolites are listed in Table 1.
17β-hydroxyandrost-1, 4-diene-3-one (Boldenone) (II)
Colorless crystalline compound; yield 24.5%; mp 169–172°C;
Rf (acetone/chloroform 3.5:6.5, v/v): 0.71; IR νmax 3489,
1666, 1619 cm−1; MS (EI) m/z: 286 (M+, C19H26O2), 227,
159, 147, 121, 91, 77; 1H NMR (CDCl3, 500 MHz) δ 7.07
































Figure 1 The structure of androstadienedione (I) and its metabolites; 17β-Hydroxyandrost-1,4-diene-3-one (II), 11α-Hydroxyandrost-1,
4-diene-3,17-dione (III) and 12β-Hydroxyandrost-1,4-diene -3,17-dione (IV).
Table 1 13C NMR data determined in CDCl3 at 500 MHz
for compounds I-IV
Carbon atom I II III IV
1 155.20 156.00 158.81 155.35
2 127.60 127.46 128.80 127.66
3 186.00 186.45 186.77 186.28
4 124.08 123.83 124.71 124.10
5 168.19 169.30 167.66 168.33
6 32.29 32.78 32.85 32.48
7 31.21 33.14 29.70 33.32
8 35.08 35.56 33.96 34.35
9 52.31 52.44 60.48 52.13
10 43.39 43.6 43.0 43.48
11 22.07 22.50 67.69 36.03
12 32.51 36.30 42.29 85.97
13 47.62 43.1 47.85 42.64
14 50.41 50.09 49.59 44.13
15 21.88 23.53 21.85 22.16
16 35.58 30.32 35.79 35.53
17 219.66 81.41 218.25 216.31
18 13.80 11.17 14.59 11.50
19 18.70 18.72 18.65 18.72
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(1H, m, H-16α), 1.55 (1H, m, H-16β), 1.24 (3H, s, H-19),
0.82 (3H, s, H-18); 13C NMR (CDCl3) δ 186.4 (C-3), 169.3
(C-5), 156.0 (C-1), 127.5 (C-2), 123.8 (C-4), 81.4 (C-17),
18.7 (C-19), 11.1(C-18).
11α-hydroxyandrost-1,4-diene-3,17-dione (III)
Colorless crystalline compound; yield 9.6%; mp 210–
214°C; Rf (acetone/chloroform 3.5:6.5, v/v): 0.29; IR νmax
3456, 1737, 1663, 1622 cm−1; MS (EI) m/z: 300 (M+,
C19H24O3), 282 , 231, 161, 124, 109, 84, 55;
1HNMR
(CDCl3, 500 MHz): δ 7.27 (1H, d, J = 10 Hz, H-1), 6.15
(1H, d, J = 10 Hz, H-2), 6.08 (1H, s, H-4), 4.12 (1H, m,
H-11β), 2.31(1H, m, H-12β), 1.54 (1H, m, H-12α), 1.24
(3H, s, H-19), 0.96 (3H, s, H-18); 13CNMR (CDCl3) δ
218.2 (C-17), 186.7 (C-3), 167.6 (C-5), 158.8 (C-1), 128.8
(C-2), 124.7 (C-4), 67.69 (C-11), 18.6 (C-19), 14.5 (C-18).
12β-hydroxyandrost-1,4-dien-3,17-dione (IV)
Colorless crystalline compound; yield 10.3%; mp 164–
167°C; Rf (acetone/chloroform, 3.5:6.5 v/v): 0.60; IR νmax
3408, 1741, 1661, 1618 cm−1; MS (EI) m/z 300 (M+,
C19H24O3), 161, 147, 134, 122, 91, 55;
1H NMR (CDCl3,
500 MHz) δ 7.06 (1H, d, J = 10 Hz, H-1), 6.24 (1H, d,
J = 10 Hz, H-2), 6.07 (1H, s, H-4), 3.74 (1H, s, H-12),
2.03, 1.45 (1H, m, H-11), 1.25 (3H, s, H-19), 0.79 (3H, s,
H-18); 13C NMR (CDCl3) δ 216.3 (C-17), 186.3 (C-3),
168.3 (C-5), 155.3 (C-1), 127.6 (C-2), 124.1 (C-4), 85.97
(C-12), 18.7 (C-19), 11.50 (C-18).
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The EI-MS spectrum of compound II showed the M+ at
m/z 286 which corresponds to the molecular formula
C19H26O2, 2 a.m.u. higher than the molecular weight of
parent compound and thus indicated a possible hydro-
genation of compound I. The IR spectrum showed an ab-
sorbance at 3489 cm- 1, characteristic of a hydroxyl group.
The lack of absorption band at 1736 cm−1 (17-ketone) and
the existence of a peak at 3489 cm−1, verify the reduction
of the carbonyl group to a hydroxyl group at C-17 pos-
ition. The 1H-NMR spectrum of II showed an additional
methine proton signal at δ 3.64 that is assigned to 17-H.
This modification is confirmed by the appearance of a
new methine carbon signal at δ 81.41 in 13C-NMR spec-
tra. The stereochemistry of the newly formed hydroxyl
group was deduced to be β, based on the chemical shift of
17-H (δ 3.64), its coupling constant (J = 8.5 Hz) and split-
ting pattern (triplet) which is in agreement with the pub-
lished data for a C-17α proton in 17β-hydroxysteroids
[13,16]. This pattern is often seen when the 17β position
is substituted with a hydroxyl group (e.g. pregnan-20-
ones7 or androstan-17β-ols) [17]. In the case of 17α-
hydroxy steroids, the splitting of H-17 β is generally a
doublet [18].
The EI-MS spectrum of the transformed product III,
showed the M+ at m/z 300 (calcd for C19H24O3 300.1749),
which was 16 a.m.u. higher than the molecular weight of
compound I, thus suggesting the possible hydroxylation of
it. The IR spectrum displayed hydroxyl signal at 3456 cm−1.
1H- and 13C-NMR spectra were very similar to those of
the substrate, except for a new downfield methine proton
signal at δ 4.12 (ddd, J11β,12β = 12.2 Hz, J11β,9α = 10.3 Hz,
J11β,12α = 5.4 Hz) which was assigned to the methine H-11
geminal to OH and with a downfield methine carbon sig-
nal at δ 67.69. This finding is also confirmed by the data
reported in literature for this compound [13].
The mass spectrum for compound IV, showed the mo-
lecular ion peak at m/z 300 (C19H24O3), which suggested
the possible insertion of one oxygen atom in the structure
of the substrate (I). The IR spectrum, showed two car-
bonyl absorption bands at 1741 and 1661 cm−1 for C-17
and C-3 respectively. The absorbance at 3408 cm−1, con-
firmed the existance of a hydroxyl group. Melting point,
13C-NMR and 1H-NMR spectral data, assignments and
chemical shifts for this compound were in agreement with
those which have been reported by Zafar et al. in 2013 for
12β-hydroxyandrost-1,4-dien-3,17-dione [19].
Discussion
In light of the results obtained in this study, it appears
that the A. brasiliensis transformation of ADD led to the
formation of three major bioproducts. The bioconver-
sion characteristics observed were 17-ketone reduction,
11α and 12β-hydroxylation.ADD is one of the important intermediates for produ-
cing some valuable pharmaceutical steroid compounds
and has been used in many studies as a substrate of the
biotransformation experiments [20]. Compound II, Bol-
denone, also called 1-dehydrotestosterone or androsta-1,
4-dien-17β-ol-3-one, is a steroid which only differs from
testosterone by one double bond at position 1. Re-
duction of 17-keto group of ADD results in formation of
boldenone. Boldenone with its low androgenic cha-
racteristics but strong anabolic characteristics allows im-
proving anabolic processes like growth and development
of muscle mass without any undesired side-effects [21].
Reduction of 17-carbonyl group of ADD has been
reported previously by Mucor racemosus and Acremonium
strictum and Cephalosporium aphidicola fermention
[11,12]. 11α-hydroxyandrost-1,4-diene-3,17-dione (III)
which is used in the preparation of anti-osteoporosis ac-
tive compounds, has been previously obtained by ADD
biotransformation in Cephalosporium aphidicola, Rhizo-
pus arrhizus and Aspergillus ochraceus culture media
[13,20,22]. It has also been reported by fermentation of di-
hydrotestosterone (DHT) with Gibberella fujikuroi. This
compound which is significant and specific inhibitor of
butyrylcholinesterase (BChE), in comparison to standard
drug, galanthamine. 12β-hydroxyandrost-1,4-diene-3,17-
dione (IV) was also another hydroxylated steroid which
has been obtained from DHT biotransformation by G.
fujikuroi [19]. Although hydroxylation of steroidal sub-
strates is common by filamentous fungi, hydroxylation at
C-12 position is relatively rare [6]. The 12β-hydroxylation
is proprietary reaction for filamentous fungi and is
unknown in humans [23]. Introduction of a C-12
substituent and especially a β C-12 substituent into
glucocorticoids improves their usefulness as topical
anti-inflammatories by increasing their topical activity
relative to their systemic activity [24]. Therefore from
an industrial viewpoint, the ability of A. brasiliensis
to carry out 12β-hydroxylation on ADD substrate
may be interesting as a process for production of
glucocorticoids.
Conclusion
The present research shows that the transformation of
androstendienedione using A. brasiliensis whole cells
yielded interesting transformation products. The ob-
served modifications included hydroxylation at C-11α,
C-12β and 17-carbonyl reduction into the related C-17β
hydroxyl forms. These products were separated and
characterized on the basis of their spectral data. To the
best of our knowledge, there are only few reports for
ADD biotransformation by microorganisms and also no
report for A. brasiliensis. Therefore A. brasiliensis could
be considered as efficient biocatalyst for preparation of
new steroids with commercial significance.
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